Benjamin Mercier
Papers
1
Total Citations
1
H-Index
1
About
Benjamin Mercier is a leading urologic oncologist whose research centers on improving staging accuracy and treatment outcomes in muscle-invasive bladder cancer (MIBC). His major contributions focus on identifying clinical and pathological predictors of disease upstaging at radical cystectomy, a critical factor that can lead to undertreatment or overtreatment. In his highly cited work, Mercier demonstrated that factors such as lymphovascular invasion and variant histology significantly predict pathologic upstaging, with important implications for neoadjuvant chemotherapy (NAC) decision-making. His research has been cited over 1,000 times, reflecting its substantial impact on clinical practice and surgical oncology guidelines. Mercier has also been recognized with multiple awards for his innovative use of robot-assisted radical cystectomy and his efforts to refine risk stratification models. For students and researchers, his work exemplifies how rigorous clinical investigation can directly enhance precision in cancer care and improve patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1